These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 11313257

  • 1. The interleukin-13 receptor alpha2 chain: an essential component for binding and internalization but not for interleukin-13-induced signal transduction through the STAT6 pathway.
    Kawakami K, Taguchi J, Murata T, Puri RK.
    Blood; 2001 May 01; 97(9):2673-9. PubMed ID: 11313257
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors.
    Murata T, Taguchi J, Puri RK.
    Blood; 1998 May 15; 91(10):3884-91. PubMed ID: 9573026
    [Abstract] [Full Text] [Related]

  • 3. Induction of the IL-13 receptor alpha2-chain by IL-4 and IL-13 in human keratinocytes: involvement of STAT6, ERK and p38 MAPK pathways.
    David M, Ford D, Bertoglio J, Maizel AL, Pierre J.
    Oncogene; 2001 Oct 11; 20(46):6660-8. PubMed ID: 11709700
    [Abstract] [Full Text] [Related]

  • 4. Identification of distinct roles for a dileucine and a tyrosine internalization motif in the interleukin (IL)-13 binding component IL-13 receptor alpha 2 chain.
    Kawakami K, Takeshita F, Puri RK.
    J Biol Chem; 2001 Jul 06; 276(27):25114-20. PubMed ID: 11352909
    [Abstract] [Full Text] [Related]

  • 5. Heterogeneity in interleukin-13 receptor expression and subunit structure in squamous cell carcinoma of head and neck: differential sensitivity to chimeric fusion proteins comprised of interleukin-13 and a mutated form of Pseudomonas exotoxin.
    Joshi BH, Kawakami K, Leland P, Puri RK.
    Clin Cancer Res; 2002 Jun 06; 8(6):1948-56. PubMed ID: 12060640
    [Abstract] [Full Text] [Related]

  • 6. Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer.
    Kawakami K, Kawakami M, Joshi BH, Puri RK.
    Cancer Res; 2001 Aug 15; 61(16):6194-200. PubMed ID: 11507072
    [Abstract] [Full Text] [Related]

  • 7. Reconstitution of a functional human type II IL-4/IL-13 receptor in mouse B cells: demonstration of species specificity.
    Andrews R, Rosa L, Daines M, Khurana Hershey G.
    J Immunol; 2001 Feb 01; 166(3):1716-22. PubMed ID: 11160216
    [Abstract] [Full Text] [Related]

  • 8. Characterization of the interaction between interleukin-13 and interleukin-13 receptors.
    Arima K, Sato K, Tanaka G, Kanaji S, Terada T, Honjo E, Kuroki R, Matsuo Y, Izuhara K.
    J Biol Chem; 2005 Jul 01; 280(26):24915-22. PubMed ID: 15870068
    [Abstract] [Full Text] [Related]

  • 9. Level of expression of IL-13R alpha 2 impacts receptor distribution and IL-13 signaling.
    Daines MO, Tabata Y, Walker BA, Chen W, Warrier MR, Basu S, Hershey GK.
    J Immunol; 2006 Jun 15; 176(12):7495-501. PubMed ID: 16751396
    [Abstract] [Full Text] [Related]

  • 10. IL-13Ralpha2 is a glioma-restricted receptor for interleukin-13.
    Mintz A, Gibo DM, Slagle-Webb B, Christensen ND, Debinski W.
    Neoplasia; 2002 Jun 15; 4(5):388-99. PubMed ID: 12192597
    [Abstract] [Full Text] [Related]

  • 11. Functional characterization of IL-13 receptor alpha2 gene promoter: a critical role of the transcription factor STAT6 for regulated expression.
    David MD, Bertoglio J, Pierre J.
    Oncogene; 2003 May 29; 22(22):3386-94. PubMed ID: 12776189
    [Abstract] [Full Text] [Related]

  • 12. Gene transfer of interleukin 13 receptor alpha2 chain dramatically enhances the antitumor effect of IL-13 receptor-targeted cytotoxin in human prostate cancer xenografts.
    Kawakami K, Husain SR, Bright RK, Puri RK.
    Cancer Gene Ther; 2001 Nov 29; 8(11):861-8. PubMed ID: 11773976
    [Abstract] [Full Text] [Related]

  • 13. Diminished responses to IL-13 by human monocytes differentiated in vitro: role of the IL-13Ralpha1 chain and STAT6.
    Hart PH, Bonder CS, Balogh J, Dickensheets HL, Vazquez N, Davies KV, Finlay-Jones JJ, Donnelly RP.
    Eur J Immunol; 1999 Jul 29; 29(7):2087-97. PubMed ID: 10427971
    [Abstract] [Full Text] [Related]

  • 14. IL-4 receptor alpha is an important modulator of IL-4 and IL-13 receptor binding: implications for the development of therapeutic targets.
    Andrews AL, Holloway JW, Holgate ST, Davies DE.
    J Immunol; 2006 Jun 15; 176(12):7456-61. PubMed ID: 16751391
    [Abstract] [Full Text] [Related]

  • 15. The interleukin-4/interleukin-13 receptor of human synovial fibroblasts: overexpression of the nonsignaling interleukin-13 receptor alpha2.
    Feng N, Lugli SM, Schnyder B, Gauchat JF, Graber P, Schlagenhauf E, Schnarr B, Wiederkehr-Adam M, Duschl A, Heim MH, Lutz RA, Moser R.
    Lab Invest; 1998 May 15; 78(5):591-602. PubMed ID: 9605184
    [Abstract] [Full Text] [Related]

  • 16. Specifically targeted killing of interleukin-13 (IL-13) receptor-expressing breast cancer by IL-13 fusion cytotoxin in animal model of human disease.
    Kawakami K, Kawakami M, Puri RK.
    Mol Cancer Ther; 2004 Feb 15; 3(2):137-47. PubMed ID: 14985454
    [Abstract] [Full Text] [Related]

  • 17. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M, Kawakami K, Takahashi S, Abe M, Puri RK.
    Cancer; 2004 Sep 01; 101(5):1036-42. PubMed ID: 15329913
    [Abstract] [Full Text] [Related]

  • 18. Kinetic analysis of the interleukin-13 receptor complex.
    Andrews AL, Holloway JW, Puddicombe SM, Holgate ST, Davies DE.
    J Biol Chem; 2002 Nov 29; 277(48):46073-8. PubMed ID: 12354755
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.
    Zhao Y, He D, Zhao J, Wang L, Leff AR, Spannhake EW, Georas S, Natarajan V.
    J Biol Chem; 2007 Apr 06; 282(14):10172-9. PubMed ID: 17287216
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.